Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Raludotatug Deruxtecan (R-DXd) Phase 2 Results Expected
Raludotatug Deruxtecan (R-DXd) • Gastrointestinal Cancer
Target Indication
Gastrointestinal Cancer
Clinical Trial
NCT06864169Last updated: 12/19/2025